EUVIMEDEUVIMED entdecken
Crossref

600.07 Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors: A Global Propensity-Matched Analysis

Ibrahim Halil Inanc, Afnan Chaudhry, Fulden Akyuz Inanc, Cagri Aksu, Arif Jan, Mehmet Cilingiroglu

JACC: Cardiovascular Interventions · 2026-03 · 19 (5) · S57

DOI: 10.1016/j.jcin.2026.01.197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2026-03. Verfasst von Ibrahim Halil Inanc und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Inanc, I. H., Chaudhry, A., Inanc, F. A., Aksu, C., Jan, A., & Cilingiroglu, M. (2026). 600.07 Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors: A Global Propensity-Matched Analysis. JACC: Cardiovascular Interventions, 19(5), S57. https://doi.org/10.1016/j.jcin.2026.01.197

Vancouver

Inanc IH, Chaudhry A, Inanc FA, Aksu C, Jan A, Cilingiroglu M. 600.07 Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors: A Global Propensity-Matched Analysis. JACC: Cardiovascular Interventions. 2026;19(5):S57. doi:10.1016/j.jcin.2026.01.197

BibTeX
@article{Inanc2026,
  author = {Inanc, Ibrahim Halil and Chaudhry, Afnan and Inanc, Fulden Akyuz and Aksu, Cagri and Jan, Arif and Cilingiroglu, Mehmet},
  title = {600.07 Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors: A Global Propensity-Matched Analysis},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {5},
  pages = {S57},
  doi = {10.1016/j.jcin.2026.01.197}
}
Kostenlos starten →